Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 17 studies | 45% ± 18% |
Insufficient scRNA-seq data for expression of MAPK15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1891.18 | 652 / 653 | 76% | 11.89 | 462 / 605 |
kidney | 100% | 750.29 | 89 / 89 | 66% | 13.69 | 592 / 901 |
lung | 99% | 1402.06 | 570 / 578 | 58% | 9.02 | 669 / 1155 |
pancreas | 97% | 272.69 | 317 / 328 | 58% | 7.77 | 103 / 178 |
ovary | 48% | 92.77 | 87 / 180 | 97% | 52.44 | 419 / 430 |
uterus | 83% | 661.99 | 141 / 170 | 56% | 14.06 | 256 / 459 |
breast | 64% | 238.93 | 294 / 459 | 70% | 17.13 | 779 / 1118 |
esophagus | 65% | 126.95 | 933 / 1445 | 61% | 7.00 | 112 / 183 |
prostate | 91% | 297.00 | 222 / 245 | 14% | 1.51 | 72 / 502 |
intestine | 53% | 86.07 | 508 / 966 | 48% | 6.27 | 255 / 527 |
ureter | 0% | 0 | 0 / 0 | 100% | 80.94 | 1 / 1 |
bladder | 43% | 56.62 | 9 / 21 | 54% | 7.55 | 273 / 504 |
skin | 72% | 227.50 | 1296 / 1809 | 9% | 1.10 | 41 / 472 |
stomach | 29% | 38.01 | 105 / 359 | 49% | 5.34 | 140 / 286 |
brain | 49% | 301.21 | 1300 / 2642 | 7% | 1.23 | 47 / 705 |
spleen | 51% | 71.38 | 124 / 241 | 0% | 0 | 0 / 0 |
adipose | 29% | 86.37 | 346 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 24% | 2.07 | 11 / 45 |
heart | 13% | 17.73 | 111 / 861 | 0% | 0 | 0 / 0 |
liver | 2% | 2.26 | 4 / 226 | 10% | 2.04 | 40 / 406 |
blood vessel | 9% | 11.77 | 126 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.40 | 2 / 29 |
adrenal gland | 1% | 0.72 | 2 / 258 | 2% | 0.20 | 5 / 230 |
eye | 0% | 0 | 0 / 0 | 3% | 0.17 | 2 / 80 |
muscle | 1% | 1.27 | 8 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 3.09 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1904355 | Biological process | positive regulation of telomere capping |
GO_0000165 | Biological process | MAPK cascade |
GO_0003400 | Biological process | regulation of COPII vesicle coating |
GO_0007029 | Biological process | endoplasmic reticulum organization |
GO_0090494 | Biological process | dopamine uptake |
GO_0006974 | Biological process | DNA damage response |
GO_1905188 | Biological process | positive regulation of metaphase/anaphase transition of meiosis I |
GO_1905832 | Biological process | positive regulation of spindle assembly |
GO_1902017 | Biological process | regulation of cilium assembly |
GO_1904491 | Biological process | protein localization to ciliary transition zone |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0010506 | Biological process | regulation of autophagy |
GO_0051973 | Biological process | positive regulation of telomerase activity |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0032212 | Biological process | positive regulation of telomere maintenance via telomerase |
GO_0005576 | Cellular component | extracellular region |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005814 | Cellular component | centriole |
GO_0005930 | Cellular component | axoneme |
GO_0005911 | Cellular component | cell-cell junction |
GO_0005776 | Cellular component | autophagosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0072687 | Cellular component | meiotic spindle |
GO_0036064 | Cellular component | ciliary basal body |
GO_0005634 | Cellular component | nucleus |
GO_0004707 | Molecular function | MAP kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0016301 | Molecular function | kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | MAPK15 |
Protein name | Mitogen-activated protein kinase 15 (MAP kinase 15) (MAPK 15) (EC 2.7.11.24) (Extracellular signal-regulated kinase 7) (ERK-7) (Extracellular signal-regulated kinase 8) (ERK-8) Mitogen-activated protein kinase 15 (EC 2.7.11.24) |
Synonyms | ERK7 ERK8 |
Description | FUNCTION: Atypical MAPK protein that regulates several process such as autophagy, ciliogenesis, protein trafficking/secretion and genome integrity, in a kinase activity-dependent manner . Controls both, basal and starvation-induced autophagy throught its interaction with GABARAP, MAP1LC3B and GABARAPL1 leading to autophagosome formation, SQSTM1 degradation and reduced MAP1LC3B inhibitory phosphorylation . Regulates primary cilium formation and the localization of ciliary proteins involved in cilium structure, transport, and signaling . Prevents the relocation of the sugar-adding enzymes from the Golgi to the endoplasmic reticulum, thereby restricting the production of sugar-coated proteins . Upon amino-acid starvation, mediates transitional endoplasmic reticulum site disassembly and inhibition of secretion . Binds to chromatin leading to MAPK15 activation and interaction with PCNA, that which protects genomic integrity by inhibiting MDM2-mediated degradation of PCNA . Regulates DA transporter (DAT) activity and protein expression via activation of RhoA . In response to H(2)O(2) treatment phosphorylates ELAVL1, thus preventing it from binding to the PDCD4 3'UTR and rendering the PDCD4 mRNA accessible to miR-21 and leading to its degradation and loss of protein expression . Also functions in a kinase activity-independent manner as a negative regulator of growth (By similarity). Phosphorylates in vitro FOS and MBP . During oocyte maturation, plays a key role in the microtubule organization and meiotic cell cycle progression in oocytes, fertilized eggs, and early embryos (By similarity). Interacts with ESRRA promoting its re-localization from the nucleus to the cytoplasm and then prevents its transcriptional activity . . |
Accessions | ENST00000615253.4 [Q8TD08-1] Q8TD08 A0A1C7CYZ1 ENST00000395107.8 [Q8TD08-3] ENST00000395108.2 [Q8TD08-2] ENST00000620781.2 ENST00000338033.9 [Q8TD08-1] |